Cargando…
Evaluation of Cellular Immune Response to Adeno-Associated Virus-Based Gene Therapy
The number of approved or investigational late phase viral vector gene therapies (GTx) has been rapidly growing. The adeno-associated virus vector (AAV) technology continues to be the most used GTx platform of choice. The presence of pre-existing anti-AAV immunity has been firmly established and is...
Autores principales: | Gorovits, Boris, Azadeh, Mitra, Buchlis, George, Fiscella, Michele, Harrison, Travis, Havert, Mike, Janetzki, Sylvia, Jawa, Vibha, Long, Brian, Mahnke, Yolanda D., McDermott, Andrew, Milton, Mark, Nelson, Robert, Vettermann, Christian, Wu, Bonnie |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10132926/ https://www.ncbi.nlm.nih.gov/pubmed/37101079 http://dx.doi.org/10.1208/s12248-023-00814-5 |
Ejemplares similares
-
Evaluation of the Humoral Response to Adeno-Associated Virus-Based Gene Therapy Modalities Using Total Antibody Assays
por: Gorovits, Boris, et al.
Publicado: (2021) -
Monitoring cell-mediated immune responses in AAV gene therapy clinical trials using a validated IFN-γ ELISpot method
por: Patton, Kathryn S., et al.
Publicado: (2021) -
Immune monitoring technology primer: the enzyme-linked immunospot (Elispot) and Fluorospot assay
por: Janetzki, Sylvia
Publicado: (2015) -
Adeno-Viren
por: Falke, Dietrich
Publicado: (2009) -
Key Diagnostic Finding in a Condition with Variable Clinical Presentations
por: Sukumaran, Anju, et al.
Publicado: (2013)